January 29, 2015 9:27 AM ET

Pharmaceuticals

Company Overview of Heptares Therapeutics Ltd.

Company Overview

Heptares Therapeutics Ltd. operates as a drug discovery company. It designs and develops drugs to tackle diseases involving the nervous system and metabolism. The company was founded in 2007 and is based in Welwyn Garden City, United Kingdom.

BioPark

Broadwater Road

Welwyn Garden City,  AL7 3AX

United Kingdom

Founded in 2007

Phone:

44 17 0735 8628

Key Executives for Heptares Therapeutics Ltd.

Chief Executive Officer
President of USA Operations
Age: 47
Head of Chemistry
Chief Medical Officer and Vice President of Development
Age: 61
Chief Business Officer
Compensation as of Fiscal Year 2014.

Heptares Therapeutics Ltd. Key Developments

Heptares Technology Enables Breakthrough in Drug Discovery Collaboration with AstraZeneca

Heptares Therapeutics announced significant progress in its drug discovery collaboration with AstraZeneca. Using Heptares proprietary StaR technology, the first-ever stable version of Protease-Activated Receptor-2 (PAR2) in a therapeutically relevant form has been generated, from which its X-ray structure has been solved. PAR2 is a G protein-coupled receptor (GPCR) that is a well-validated target for multiple indications in pain and inflammatory diseases. Working with scientists at AstraZeneca, the PAR2 StaR protein was used to screen compound libraries resulting in the identification of a hit series of small molecules that bind and block its activity. The X-ray structure information, which yields new details about the unusual binding pocket of PAR2, is now being used at AstraZeneca to further optimize the hit molecules; to increase their binding affinity, potency as antagonists as well as improving their drug-like properties (e.g. oral bioavailability and stability).

Heptares Therapeutics Ltd. Presents at Boston Biotech Conferences LLC's The East Meets West CEO conference, Jan-10-2015 through Jan-11-2015

Heptares Therapeutics Ltd. Presents at Boston Biotech Conferences LLC's The East Meets West CEO conference, Jan-10-2015 through Jan-11-2015. Venue: Four Seasons Hotel, 757 Market St, San Francisco, CA 94103. Presentation Date & Speakers: Jan-10-2015, Daniel Grau, President of USA Operations. Jan-11-2015, Malcolm Weir, Chief Executive Officer.

Heptares Therapeutics Ltd. Presents at EBD Group's Biopharm America 2014 Conference, Sep-22-2014 through Sep-24-2014

Heptares Therapeutics Ltd. Presents at EBD Group's Biopharm America 2014 Conference, Sep-22-2014 through Sep-24-2014. Venue: Boston Marriott Copley Place, 110 Huntington Avenue, Boston, MA 02116, United States. Presentation Date & Speakers: Sep-22-2014, Daniel Grau, President of USA Operations. Sep-24-2014.

Similar Private Companies By Industry

Company Name Region
Q-One Biotech Group Ltd. Europe
Sucampo Pharma Europe Ltd. Europe
Laycock’s Agricultural Chemists Europe
Chefaro UK, Ltd Europe
Merck Sharp & Dohme (Holdings) Limited Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Heptares Therapeutics Ltd., please visit www.heptares.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.